Ecrins Therapeutics
Paris, Ile-de-France, France
About Ecrins Therapeutics
Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being developped for human and veterinary oncology applications and is currently in the regulatory preclinical phase. Our other R&D programs are in the discovery phase.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.7M
- Last round: Equity Crowdfunding (May 2015)
- Website: ecrins-therapeutics.comenhome
- Phone: +33 1 43 25 01 50
Industries & Categories
Biotechnology, Life Science, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/ecrins-therapeutics-2582322 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.